AAAAAA
Results: 26-50/80
Authors:
DEBARI VA
AKL ZA
Citation: Va. Debari et Za. Akl, LABORATORY AND CLINICAL-FEATURES OF AUTOIMMUNITY IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, Journal of clinical immunoassay, 17(2), 1994, pp. 118-127
Authors:
OMAR R
Citation: R. Omar, HEAT-SHOCK PROTEINS IN AUTOIMMUNE-DISEASE, Journal of clinical immunoassay, 17(2), 1994, pp. 129-132
Authors:
APPLE FS
Citation: Fs. Apple, DIAGNOSTIC MARKERS FOR DETECTION OF MYOCARDIAL-CELL DAMAGE AND MONITORING REPERFUSION, Journal of clinical immunoassay, 17(1), 1994, pp. 6-6
Authors:
CHASE G
Citation: G. Chase, CLAS AT 20 - A HISTORY, Journal of clinical immunoassay, 17(1), 1994, pp. 17-23
Authors:
APPLE FS
PREESE LM
Citation: Fs. Apple et Lm. Preese, CREATINE KINASE-MB - DETECTION OF MYOCARDIAL-INFARCTION AND MONITORING REPERFUSION, Journal of clinical immunoassay, 17(1), 1994, pp. 24-29
Authors:
PANTEGHINI M
Citation: M. Panteghini, CREATINE-KINASE MB ISOFORMS, Journal of clinical immunoassay, 17(1), 1994, pp. 30-34
Authors:
VAIDYA HC
Citation: Hc. Vaidya, MYOGLOBIN - AN EARLY BIOCHEMICAL MARKER FOR THE DIAGNOSIS OF ACUTE MYOCARDIAL-INFARCTION, Journal of clinical immunoassay, 17(1), 1994, pp. 35-39
Authors:
BODOR GS
Citation: Gs. Bodor, CARDIAC TROPONIN-I - A HIGHLY SPECIFIC BIOCHEMICAL MARKER FOR MYOCARDIAL-INFARCTION, Journal of clinical immunoassay, 17(1), 1994, pp. 40-44
Authors:
WU AH
Citation: Ah. Wu, CARDIAC TROPONIN-T - BIOCHEMICAL, ANALYTICAL, AND CLINICAL ASPECTS, Journal of clinical immunoassay, 17(1), 1994, pp. 45-48
Authors:
MARCUS M
Citation: M. Marcus, CHASE,GRAFTON,D. - IN-MEMORIAM, Journal of clinical immunoassay, 16(4), 1993, pp. 254-254
Authors:
NORDBLOM GD
Citation: Gd. Nordblom, A FINAL WORD OF THANKS, Journal of clinical immunoassay, 16(4), 1993, pp. 255-255
Authors:
HEAL A
Citation: A. Heal, LIGANDS IN RESEARCH - DEVELOPMENT AND APPLICATION, Journal of clinical immunoassay, 16(4), 1993, pp. 256-257
Authors:
NG RH
Citation: Rh. Ng, IMMUNOASSAY AUTOMATION - THE NEXT-GENERATION (VOL 6, PG 180, 1993), Journal of clinical immunoassay, 16(4), 1993, pp. 258-260
Authors:
GARRETT PE
Citation: Pe. Garrett, BEYOND MORTAR AND BRICKS - A CHECKLIST FOR BUILDING A CLINICAL LABORATORY, Journal of clinical immunoassay, 16(4), 1993, pp. 261-262
Authors:
KRICKA LJ
Citation: Lj. Kricka, TRENDS IN IMMUNOASSAY TECHNOLOGIES, Journal of clinical immunoassay, 16(4), 1993, pp. 267-271
Authors:
GOWER WR
Citation: Wr. Gower, LIGAND-BINDING ASSAYS IN THE RESEARCH LABORATORY, Journal of clinical immunoassay, 16(4), 1993, pp. 272-275
Authors:
DEWANJEE MK
KAPADVANJWALA M
KRISHAN A
SERAFINI AN
GHAFOURIPOUR AK
OATES EL
LOPEZ DM
SFAKIANAKIS GN
Citation: Mk. Dewanjee et al., RADIOLABELED ANTISENSE OLIGODEOXYNUCLEOTIDES - IN-VITRO AND IN-VIVO APPLICATIONS, Journal of clinical immunoassay, 16(4), 1993, pp. 276-289
FROM MURINE TO HUMAN MONOCLONAL-ANTIBODIES - AN OVERVIEW OF THE ROLE OF IMMUNOSCINTIGRAPHY IN CANCER
Authors:
SERAFINI AN
MALLIN W
EZUDDIN S
WATSON C
GANZ W
SOTO R
GREEN N
SFAKIANAKIS GN
Citation: An. Serafini et al., FROM MURINE TO HUMAN MONOCLONAL-ANTIBODIES - AN OVERVIEW OF THE ROLE OF IMMUNOSCINTIGRAPHY IN CANCER, Journal of clinical immunoassay, 16(4), 1993, pp. 290-293
Authors:
HANSEN HJ
SHARKEY RM
SULLIVAN CL
GOLDENBERG DM
Citation: Hj. Hansen et al., HAMA INTERFERENCE WITH MURINE MONOCLONAL ANTIBODY-BASED IMMUNOASSAYS, Journal of clinical immunoassay, 16(4), 1993, pp. 294-299
Authors:
SCHEFFEL U
Citation: U. Scheffel, IN-VIVO BRAIN RECEPTOR IMAGING, Journal of clinical immunoassay, 16(4), 1993, pp. 300-310
Authors:
EFANGE SMN
MACH RH
Citation: Smn. Efange et Rh. Mach, IN-VIVO DETECTION OF RECEPTORS, Journal of clinical immunoassay, 16(4), 1993, pp. 311-329
Authors:
NG RH
Citation: Rh. Ng, IMMUNOASSAY AUTOMATION - THE NEXT-GENERATION, Journal of clinical immunoassay, 16(3), 1993, pp. 180-180
Authors:
DORIZZI RM
GIAVARINA D
Citation: Rm. Dorizzi et D. Giavarina, CIBA CORNING ACS .180. A USERS PERSPECTIVE FROM EUROPE, Journal of clinical immunoassay, 16(3), 1993, pp. 183-184
Authors:
SCHUMACHER RT
GARRETT PE
Citation: Rt. Schumacher et Pe. Garrett, INFECTIOUS-DISEASE TESTING - ON THE FRONT LINES, Journal of clinical immunoassay, 16(3), 1993, pp. 185-185
Authors:
GARRETT PE
Citation: Pe. Garrett, METHOD EVALUATION UNDER CLIA - YOU CANT GET AWAY WITH A 510(K), Journal of clinical immunoassay, 16(3), 1993, pp. 186